For World AIDS Day, guest authors Athena Cross, Carl Baloney and Jesse Milan Jr. call attention to diminishing HIV-related philanthropic support, despite prevailing racial equity gaps in diagnoses and treatment.
Read MoreThe Engelstad Foundation supported Touro University Nevada's lone biomedical lab when few other funders would. A recent discovery there could lead to new treatments for HIV, and even cancer, Alzheimer’s and more.
Read MorePhilanthropy makes up only a small fraction of spending on research and support for people with HIV, still a major threat around the world. In the push for a vaccine, Gates and Gilead are leading the pack.
Read MoreTo bolster the world’s flagging campaign to halt HIV transmission, two funds have joined forces on a new effort to support the delivery of preventative medicine in up to five African countries.
Read MoreWe sit down with former WNBA player Clarisse Machanguana, Mozambique’s most storied basketball player. She talks about going back home to start a foundation focused on girls and youth, and why she’s back in the U.S.
Read MoreCan funders back research conducted by Global North institutions in the Global South without becoming extractive? Guest contributor Terry McGovern gives us five ways that work can take place more equitably.
Read MoreGilead Sciences is a leading player in HIV/AIDS funding in the U.S. South, with a major grantmaking program aimed at tackling an epidemic that’s still raging in this part of the country. Where’s the money going?
Read MoreWith alarm bells sounding, more HIV/AIDS funding in the South lately is coming from foundations that typically have a much more national and international focus. Here's an example.
Read More
Whether you raise money or give it away,
Inside Philanthropy is an essential resource.
